Symptom Burden, Physical Activity Predict Overall Recovery After Allogeneic Hematopoietic Stem Cell Transplantation
Analysis of patient-reported questionnaire results showed predictors of recovery for patients undergoing allo-HSCT.
Diagnosis & Disease Information
Determining Candidacy of Patients With MF for Allogeneic Stem Cell Transplantation
A team of researchers presented their strategies for choosing patients with myelofibrosis who may be candidates for allogeneic stem cell transplantation and guiding their treatment.
Management of Clostridioides difficile Infections After Hematopoietic Stem Cell Transplantation
This review discusses the importance of an early diagnosis of C diff infection in patients who have undergone HSCT and the recommended treatment options.
Single-Dose Regimen Effective as Acute GVHD Prophylaxis After HSCT With Matched-Unrelated Donors
Researchers sought to determine if a single dose of posttransplant cyclophosphamide is as effective as a 2-dose regimen in patients undergoing hematopoietic cell transplantation with matched-unrelated donors.
Durable Response Achieved With Belumosudil in Patients With Chronic Graft-Versus-Host Disease
Researchers report on results of a phase 2 clinical trial on a novel agent for the treatment of chronic graft-versus-host-disease in patients who have undergone hematopoietic cell transplantation.
Use of Abatacept With Unrelated Donor HCT Improves Acute GVHD, SGFS
ABA2 results suggest abatacept improved acute and severe GVHD at day +100 in patients treated with a calcineurin inhibitor and methotrexate.
Survival Improving for Patients With Acute Lymphoblastic Leukemia Who Experience Relapse Following HSCT
Researchers identify factors that influence relapse after HSCT in patients with acute lymphoblastic leukemia.
Significant Physician-Associated Barriers for Patient Access to Hematopoietic Cell Transplantation
A comparison of survey responses showed that referrals to HCT consultation for are occurring at a higher rate, earlier, and for older patients.
HIGH-2-LOW Risk Assessment Tool Stratifies Patient Risk for Venous Thromboembolism
This newly developed tool used several measures to successfully stratify risk of VTE in patients with hematologic cancers.
Men at Increased Risk for Mortality Following Allogeneic Hematopoietic Stem Cell Transplant
A retrospective analysis compared survival rates after allogeneic hematopoietic stem cell transplantation in men with those of women.
- Loading...
Loading...
Loading... 
Loading...